Crilles Casper Larsen

Title: Crilles Casper Larsen: Innovator in Pharmaceutical Granulation

Introduction

Crilles Casper Larsen is a notable inventor based in Mex, Switzerland. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of granules for solid oral dose medications. With a total of 2 patents, his work has the potential to enhance the efficacy of treatments for various medical conditions.

Latest Patents

Larsen's latest patents focus on improved granular pharmaceutical preparations and the methods and apparatus for their production. These innovations are particularly beneficial for creating granules that contain 5-aminosalicylic acid (5-ASA), which is used in the treatment of inflammatory bowel disease. The granules produced through his methods exhibit a more sharply peaked length distribution and aspect ratio distribution, resulting in a significantly sharper dissolution profile after further processing. This advancement is crucial for improving the effectiveness of pharmaceutical treatments.

Career Highlights

Crilles Casper Larsen is associated with Ferring B.V., a company known for its commitment to advancing healthcare through innovative solutions. His work at Ferring has allowed him to focus on the development of pharmaceutical preparations that can lead to better patient outcomes.

Collaborations

Larsen has collaborated with esteemed colleagues such as Carsten Hoeg-Moller and Jorgen Wittendorff. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Crilles Casper Larsen's contributions to pharmaceutical granulation represent a significant advancement in the field. His innovative patents and collaborative efforts continue to pave the way for improved treatments in healthcare.